secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0000950170-23-041361
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q2 net income $823k on non-cash gain; revenue down 64% to $1.39M
------------------------------------------------------------------------

- Q2 2023 revenue $1.389M vs $3.858M in Q2 2022, down 64% due to exit of grain and body care sales.
- Net income $823k ($0.61/share) vs net loss $3.777M ($6.81 loss) in prior year; includes $4.4M non-cash warrant gain.
- Exiting Body Care brands ProVault and SoulSpring; expects $2M OpEx savings in H2 2023, $3-4M annual.
- Engaged Lake Street Capital Markets to explore strategic options including sale, merger, or capital raise.
- GoodWheat launches pancake & waffle mixes; Zola coconut water adds hundreds of retail stores in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023041361/0000950170-23-041361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023041361/rkda-20230810.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-041361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer